Your search returned 5959 results.

Results
	5701.	Effect of the multitargeted tyrosine kinase inhibitors imatinib, dasatinib, sunitinib, and sorafenib on mitochondrial function in isolated rat heart mitochondria and H9c2 cells. [electronic resource] by Will, Yvonne Dykens, James A Nadanaciva, Sashi Hirakawa, Brad Jamieson, Joseph Marroquin, Lisa D Hynes, James Patyna, Shem Jessen, Bart A Producer: 20081223 In: Toxicological sciences : an official journal of the Society of Toxicology vol. 106 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5702.	Infliximab and etanercept are equally effective in reducing enterocyte APOPTOSIS in experimental colitis. [electronic resource] by Fries, Walter Muja, Carmelo Crisafulli, Carmela Costantino, Giuseppe Longo, Giuseppe Cuzzocrea, Salvatore Mazzon, Emanuela Producer: 20081001 In: International journal of medical sciences vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5703.	Neuroprotection for ischaemic stroke: translation from the bench to the bedside. [electronic resource] by Sutherland, Brad A Minnerup, Jens Balami, Joyce S Arba, Francesco Buchan, Alastair M Kleinschnitz, Christoph Producer: 20120920 In: International journal of stroke : official journal of the International Stroke Society vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5704.	Survival of patients with advanced hepatocellular carcinoma: sorafenib versus other treatments. [electronic resource] by Kim, Hwi Young Park, Joong-Won Nam, Byung-Ho Kim, Hyun Keun Choi, Joon-Il Kim, Tae Hyun Kim, Hyun Beom Kim, Chang-Min Producer: 20120213 In: Journal of gastroenterology and hepatology vol. 26 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5705.	How to manage hypersensitivity reactions to biological agents? [electronic resource] by Barbaud, Annick Granel, Florence Waton, Julie Poreaux, Claire Producer: 20120119 In: European journal of dermatology : EJD vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5706.	The role of PI3K/mTOR inhibition in combination with sorafenib in hepatocellular carcinoma treatment. [electronic resource] by Gedaly, Roberto Angulo, Paul Chen, Changguo Creasy, Kate Townsend Spear, Brett T Hundley, Jonathan Daily, Michael F Shah, Malay Evers, B Mark Producer: 20121008 In: Anticancer research vol. 32 Availability: No items available. Save to lists Add to cart (remove)
	5707.	Long-term analysis of the efficacy and tolerability of sorafenib in advanced radio-iodine refractory differentiated thyroid carcinoma: final results of a phase II trial. [electronic resource] by Schneider, T C Abdulrahman, R M Corssmit, E P Morreau, H Smit, J W A Kapiteijn, E Producer: 20121217 In: European journal of endocrinology vol. 167 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5708.	[Targeted therapies: sequential and combined treatments]. [electronic resource] by Gross-Goupil, M Escudier, B Producer: 20100519 In: Bulletin du cancer vol. 97 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5709.	Phase II escalation study of sorafenib in patients with metastatic renal cell carcinoma who have been previously treated with anti-angiogenic treatment. [electronic resource] by Mancuso, Andrea Di Paola, Eugenio Donato Leone, Alvaro Catalano, Alfonso Calabrò, Fabio Cerbone, Linda Zivi, Andrea Messina, Carlo Alonso, Silvia Vigna, Leonardo Caristo, Rita Sternberg, Cora N Producer: 20120221 In: BJU international vol. 109 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5710.	Inhibition of epidermal growth factor-mediated ERK1/2 activation by in situ electroporation of nonpermeant [(alkylamino)methyl]acrylophenone derivatives. [electronic resource] by Brownell, H L Lydon, N B Schaefer, E Roberts, T M Raptis, L Producer: 19980427 In: DNA and cell biology vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5711.	Targeting intracellular signal transduction. A new paradigm for a brave new world of molecularly targeted therapeutics. [electronic resource] by Beeram, Muralidhar Patnaik, Amita Producer: 20030724 In: Hematology/oncology clinics of North America vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5712.	Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib. [electronic resource] by Lee, W J Lee, J L Chang, S E Lee, M W Kang, Y K Choi, J H Moon, K C Koh, J K Producer: 20100310 In: The British journal of dermatology vol. 161 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5713.	Molecular determinants of melanoma malignancy: selecting targets for improved efficacy of chemotherapy. [electronic resource] by Yang, Jinming Zaja-Milatovic, Snjezana Thu, Yee-Mon Lee, Francis Smykla, Richard Richmond, Ann Producer: 20090608 In: Molecular cancer therapeutics vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5714.	Combined tyrosine and serine/threonine kinase inhibition by sorafenib prevents progression of experimental pulmonary hypertension and myocardial remodeling. [electronic resource] by Klein, Martina Schermuly, Ralph T Ellinghaus, Peter Milting, Hendrik Riedl, Bernd Nikolova, Sevdalina Pullamsetti, Soni S Weissmann, Norbert Dony, Eva Savai, Rajkumar Ghofrani, Hossein A Grimminger, Friedrich Busch, Andreas E Schäfer, Stefan Producer: 20081202 In: Circulation vol. 118 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5715.	Metastatic sarcomatoid renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy. [electronic resource] by Golshayan, Ali Reza George, Saby Heng, Daniel Y Elson, Paul Wood, Laura S Mekhail, Tarek M Garcia, Jorge A Aydin, Hakan Zhou, Ming Bukowski, Ronald M Rini, Brian I Producer: 20090116 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5716.	A multicenter phase II study of erlotinib and sorafenib in chemotherapy-naive patients with advanced non-small cell lung cancer. [electronic resource] by Lind, Joline S W Dingemans, Anne-Marie C Groen, Harry J M Thunnissen, Frederik B Bekers, Otto Heideman, Daniëlle A M Honeywell, Richard J Giovannetti, Elisa Peters, Godefridus J Postmus, Pieter E van Suylen, Robert Jan Smit, Egbert F Producer: 20100812 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5717.	Clinical outcomes of sorafenib treatment in patients with metastatic hepatocellular carcinoma who had been previously treated with fluoropyrimidine plus platinum-based chemotherapy. [electronic resource] by Kim, Ji-Won Lee, Jeong-Ok Han, Sae-Won Oh, Do-Youn Im, Seock-Ah Kim, Tae-You Bang, Yung-Jue Producer: 20110602 In: American journal of clinical oncology vol. 34 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5718.	Effect of the tyrosine kinase inhibitors (sunitinib, sorafenib, dasatinib, and imatinib) on blood glucose levels in diabetic and nondiabetic patients in general clinical practice. [electronic resource] by Agostino, Nicole M Chinchilli, Vernon M Lynch, Christopher J Koszyk-Szewczyk, Anita Gingrich, Rebecca Sivik, Jeffrey Drabick, Joseph J Producer: 20120210 In: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5719.	Inhibition of platelet functions and thrombosis through selective or nonselective inhibition of the platelet P2 receptors with increasing doses of NF449 [4,4',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis-(carbonylimino)))tetrakis-benzene-1,3-disulfonic acid octasodium salt]. [electronic resource] by Hechler, Béatrice Magnenat, Stéphanie Zighetti, Maddalena L Kassack, Matthias U Ullmann, Heiko Cazenave, Jean-Pierre Evans, Richard Cattaneo, Marco Gachet, Christian Producer: 20050826 In: The Journal of pharmacology and experimental therapeutics vol. 314 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5720.	Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models. [electronic resource] by Chang, Yong S Adnane, Jalila Trail, Pamela A Levy, Joan Henderson, Arris Xue, Dahai Bortolon, Elizabeth Ichetovkin, Marina Chen, Charles McNabola, Angela Wilkie, Dean Carter, Christopher A Taylor, Ian C A Lynch, Mark Wilhelm, Scott Producer: 20070522 In: Cancer chemotherapy and pharmacology vol. 59 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search

Availability

Authors

Topics

Languages

Your search returned 5959 results.